All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit Know ALL.
Kjeld Schmiegelow is a clinical professor at the Department of Clinical Medicine, University of Copenhagen, DK, and Head of Pediatric Oncology and Consultant of Pediatric and Adolescent Medicine at the Juliane Marie Centre, Rigshospitalet. He is currently founder and chair of the International Ponte di Legno Toxicity Working Group, a member of the European I-BFM ALL Host Genetic Variation Working Group, and chair of the Host Genome Variant Leukemia/Lymphoma Working Group of the EU COST LEGEND network. His main research interests include the etiology of childhood cancer; leukemia biology, including CNS tumors; the pharmacology of anticancer agents, including the genetics, kinetics, dynamics, and toxicities associated with these agents; and the late somatic and psychosocial effects of childhood cancer and rehabilitation.